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Aim: Bilberry is a natural antioxidant and has been utilized as a free radical scavenger to reverse the toxic effects of oxidative stress. The
aim of this study was to investigate the effect of bilberry on cisplatin-induced toxic effects in rat kidney.
Materials and methods: Twenty-one female Wistar-albino rats were randomly divided into 3 groups: group I (control), one dose of
saline solution; group II (cisplatin), single dose of 7.5 mg/kg of cisplatin; group III (cisplatin + bilberry), single dose of 7.5 mg/kg of
cisplatin and 10 days of bilberry treatment applied as 200 mg/kg of bilberry. Malondialdehyde (MDA) levels and activities of superoxide
dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) were measured. Histopathologic damage to the kidney tissue was
analyzed via light microscopic examination.
Results: Severe necrosis, edema, hemorrhage, interstitial cell infiltration, vascular dilatation, glomerular atrophy, and tubular
degeneration were observed in group II. SOD, CAT, and GPx activities were decreased and MDA levels were increased in the cisplatin
group compared to the cisplatin + bilberry group, and the differences were statistically significant (P < 0.05). Kidney tissue damage was
significantly higher in group II than in group III (P < 0.05).
Conclusion: Bilberry is efficient in the treatment of cisplatin-induced kidney damage.
Key words: Cisplatin, nephrotoxicity, rat, bilberry, protective effect

1. Introduction
Bilberry (Vaccinium myrtillus L.) is a natural substance. It
serves as a main fruit ingredient in pies, jams, etc. Bilberry
is known as a source of flavonoids. Flavonoids have
intensive antioxidant activity (1). Bilberry has been utilized
in the treatment of cancer and heart disease because of
its free radical scavenging properties (2,3). The chemical
substances in bilberry are known as anthocyanosides (4).
Bilberry has been utilized in the treatment of intestinal,
heart, kidney, and retina diseases (3,5).
Cisplatin [CDDP, cis-diamminedichloroplatinum(II)]
is a potent antineoplastic drug used in the treatment of
solid tumors. Clinicians should pay attention to the toxic
effects of this drug (6,7). Cisplatin shows its cellular toxic
effect directly. The platinum derivatives of the drug are
responsible for the cytotoxicity (8). Cisplatin increases
the lipid peroxidation in kidney tissue. The inevitable
consequence of this reaction is the elevation of free radicals
and reactive oxygen species (ROS). These free radicals, and
especially elevated malondialdehyde (MDA) levels, lead to
cellular damage (9,10).
* Correspondence: dilek.pandir@bozok.edu.tr

Numerous studies have been performed to alter this
cisplatin-induced nephrotoxicity. The chemoprotective
agents utilized against cisplatin toxicity include selenium,
quercetin, silymarin, simvastatin, etc. (11–14). We
hypothesized that administration of bilberry could
preserve the kidney tissue. Thus, the aim of this study was
to investigate the protective effect of bilberry on cisplatininduced toxic effects in rat kidney. There is no information
about the effects of bilberry against cisplatin-induced
nephrotoxicity.
2. Materials and methods
2.1. Chemical agents
Cisplatin was purchased from Sigma Chemical Co. (St
Louis, MO, USA). Bilberry was purchased from a drugstore
in Yozgat, Turkey.
2.2. Animals and experimental protocols
The study was reviewed and approved by the Ethical
Committee of Çukurova University Medical Faculty.
Twenty-one female adult Wistar-albino rats (weight range,
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150–220 g) were divided into 3 equal groups. In group I
(control group), 1 mL of 0.9% NaCl saline solution was
given intraperitoneally (ip). In group II (cisplatin group),
a single dose of 7.5 mg/kg of cisplatin was administered
ip. In group III (cisplatin + bilberry group), 7.5 mg/
kg of cisplatin was administered ip, and 200 mg/kg of
bilberry was given orally. Bilberry treatment was applied
for 10 successive days starting 1 day before cisplatin
administration. All the rats were weighed and killed. Then
their kidneys were surgically extirpated.
2.3. Histologic examination
The kidneys were fixed in 10% formalin solution for 24
h and embedded in paraffin. The kidney tissues were
sectioned at 5 µm and stained with hematoxylin-eosin.
The sections were examined and photographed by using an
Olympus BX-51 light microscope (Olympus Corp., Tokyo,
Japan). Five microscopic fields were examined to assess the
tissues. The severity of the changes observed were scored as
follows: none (_), moderate (+), and severe (++).
2.4. Biochemical measurements
MDA levels were assessed by measuring thiobarbituric acid
(TBA). The colorimetric absorbance was determined at 532
nm (15). Specific activity was presented as nmol/mg protein.

Total SOD activity was determined according to the method
described by Marklund and Marklund (16) by assaying the
autoxidation and illumination of pyrogallol at 440 nm.
Data are expressed as USOD/mg hemoglobin. CAT enzyme
activity was measured according to the method described by
Aebi (17). GPx activity was measured using H2O2 as substrate
according to the method described by Paglia and Valentine
(18) in absorbance at 340 nm. Data are presented as UGPx/
mg hemoglobin. All of these were measured in kidney tissue.
2.5. Statistical analysis
The Statistical Package for the Social Sciences (SPSS 11.0;
SPSS Inc., Chicago, IL, USA) version 11.0 was used for
statistical analysis. The significance of differences was
calculated using one-way analysis of variance (ANOVA)
followed by Tukey’s procedure for multiple comparisons.
P < 0.05 was taken as statistically significant.
3. Results
The morphologic characteristics of the kidneys were
assessed macroscopically. There was no difference between
the groups in relation to the macroscopic features. Kidneys
in the control group were normal in histopathologic
appearance (Figures 1A and 1B). Treatment with bilberry

Figure 1. (A) Kidney section of control rats, (PT) proximal tubules, (DT) distal tubules, (G) glomerulus
(×200). (B) No apparent pathology in control rats (×400), (C) glomerular atrophy (GA) vascular dilatation
(▷) in kidney cisplatin + bilberry-treatment rats (×200).
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effectively reduced the kidney tissue damage scores in the
cisplatin + bilberry treatment group (Figure 1C).
Severe necrosis, edema, interstitial cell infiltration,
and vascular dilatation were seen in group II (Figure 2A).
Tubular degeneration and hemorrhage were massive in
group II (Figure 2B). Glomerular atrophy and hemorrhage
were observed in cisplatin-administered rats (Figure 2C).
Cellular damage was higher in the cisplatin group than
in the cisplatin + bilberry group. The histopathological

changes were scored in Table 1 as follows: none (_),
moderate (+), and severe (++).
The MDA level was significantly lower in group
III than in group II (P < 0.05). SOD, CAT, and GPx
activities decreased in the cisplatin group compared to
the cisplatin + bilberry group, and the differences were
statistically significant (P < 0.05) (Table 2). Body weight,
kidney weight, and relative kidney weight of control and
experimental rats are shown in Table 3.

Figure 2. (A) Necrosis (►), edema (*), interstitial cell infiltration (↑), and vascular dilatation (▷) in
kidney cisplatin-treatment to rats (×200). (B) Tubular degeneration (⇧) and hemorrhage (↑↑) in kidney
cisplatin-treatment rats (×200). (C) Glomerular atrophy (GA) and hemorrhage (↑↑) in kidney cisplatintreatment rats (×400).

Table 1. Grading of the histopathological changes in kidney sections of rats exposed to cisplatin/cisplatin + bilberry. The features were
scored as follows: none (_), moderate (+), and severe (++).
Groups

Necrosis

Edema

Hemorrhage

Interstitial cell
infiltration

Vascular
dilatation

Glomerular
atrophy

Tubular
degeneration

Control

-

-

-

-

-

-

-

Cisplatin (7.5 mg/kg)

++

++

++

++

++

++

++

Cisplatin + bilberry
(7.5 mg/kg + 200 mg/kg)

-

-

-

-

+

+

_
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Table 2. Effects of cisplatin treatment on superoxide dismutase (SOD), glutathione peroxidase (GPx), catalase (CAT) activities, and
malondialdehyde (MDA) levels in Wistar rat kidneys (means ± SD).
Groups (each group, n = 7)

MDA (nmol/mg protein) SOD (U/mg protein)

CAT (U/mg protein) GPx (U/mg protein)

Control

4.01 ± 0.13

54 ± 3.04

76 ± 1.08

130 ± 6.15

Cisplatin (7.5 mg/kg)

9.61 ± 0.26 a

19 ± 1.22 a

61 ± 1.12 a

47 ± 3.32 a

Cisplatin + bilberry
(7.5 mg/kg + 200 mg/kg)

6.85 ± 0.27 a,b

34 ± 3.12 a,b

68 ± 1.27 a,b

86 ± 4.45 a,b

Table 3. Body weight, kidney weight, and relative kidney weight of control and experimental rats.
Body weight (g)
Initial

Final

% Change

Absolute kidney
weight (g)

Control

227 ± 5.78

231 ± 5.46

1.76 ± 0.69

1.95 ± 0.15

0.844 ± 0.13

Cisplatin

229 ± 3.67

218.8 ± 2.40a

–4.45 ± 1.01a

1.43 ± 0.18 a

0.656 ± 0.05a

Cisplatin + bilberry

228 ± 4.08

225 ± 3.52a,b

–1.32 ± 0.44 a,b

1.77 ± 0.09 a,b

0.790 ± 0.14a,b

Groups

Relative kidney g/100
g body weight

Values are means ± SD for 7 rats in each group. Significance at P < 0.05.
a
Comparison of control and other groups.
b
Comparison of cisplatin-treated group with cisplatin and bilberry-treated groups.

4. Discussion
Many anticancer drugs have been shown to be teratogenic
and carcinogenic in experimental systems. The therapeutic
effects of cisplatin are significantly improved by dose
escalation (19). The chemotherapeutic treatments used
for cancers may damage organs such as the ovaries, liver,
and kidneys (20,21). Several theories were asserted about
cisplatin-induced nephrotoxicity. These mechanisms were
lipid peroxidation, mitochondrial dysfunction, degradation
of protein structure, and DNA injury (22–24). However, the
real mechanism is not known. The platinum components of
cisplatin bind to DNA. This process leads to DNA damage
and cell death (8). Oxidative stress is another participating
factor associated with cisplatin-induced renal damage.
SOD, CAT, and GPx activities are increased in cellular
membranes due to cisplatin-induced nephrotoxicity (25).
Quercetin is a derivative of a natural flavonoid. It
exhibits strong antioxidant activity. Estela et al. (2006)
performed a study on cisplatin-induced nephrotoxicity
and oxidative stress in rat kidneys (12). They reported
that quercetin administration reversed histological and
biochemical changes due to cisplatin. Subsequently,
spirulina, erdosteine, simvastatin, grape seed, and taurine
were studied as chemoprotective agents on cisplatininduced nephrotoxicity (14,22,26–28). Bilberry has been
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used for the treatment of oxidative stress. Various theories
have been proposed about the bilberry’s mechanism of
action. These include antioxidant activities, free radical
scavenging properties, anti-inflammatory effects, and
vasodilatory action (1,3,4). Therefore, bilberry could
be beneficial for reducing the toxic renal damage due to
cisplatin.
Both in vivo and in vitro studies indicate that
cisplatin administration results in elevated oxygen
free radicals (10,29). These oxygen free radicals cause
multiple alterations in the cells and organs of animals
that are exposed to cisplatin, which results in damage
to organs (30). In the present study the protective effect
of bilberry on cisplatin-induced toxic effects in rat
kidney was studied. The findings of our study suggest
that bilberry may be useful for reducing kidney damage
due to cisplatin. Bilberry administered ip at 200 mg/kg
preserved the renal tissue and reduced the histological
and biochemical changes. Bilberry treatment resulted in
a decrease in the level of tissue MDA and an increase in
the activities of SOD, CAT, and GPx. This is the first study
indicating the preventative effect of bilberry on cisplatininduced nephrotoxicity. Tissue damage criteria such as
degeneration, hemorrhage, interstitial cell infiltration, and
vascular dilatation were less common in the cisplatin +
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bilberry group than in the cisplatin only group. Although
our results demonstrated the protective effect of bilberry
on cisplatin-induced nephrotoxicity, large prospective
randomized trials are required.
In conclusion, bilberry has a significant therapeutic
benefit when administered with cisplatin treatment against
reductions in body and kidney weight, nephrotoxicity,

and oxidative stress. Bilberry may be used as a nutritional
supplement to protect the kidney in cancer chemotherapy
as an alternative medical resource.
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